Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
(NASDAQ: PLUR) Delayed: 2.11 +0.02 (0.96%)
Previous Close $2.09    52 Week High $ 
Open $2.11    52 Week Low $ 
Day High $2.14    P/E N/A 
Day Low $2.11    EPS $ 
Volume 2,219       

(NASDAQ: PLUR) Delayed: 2.11 +0.02 (0.96%)
Previous Close $2.09    52 Week High $ 
Open $2.11    52 Week Low $ 
Day High $2.14    P/E N/A 
Day Low $2.11    EPS $ 
Volume 2,219